Continuous automated blood sampling including glucose measurement in an animal model
Continuous automated blood sampling based on an animal model
SeraMaster Version 2 – Intravenous blood glucose measurement with subjects with type 1 diabetes
IV blood sampling for glucose measurement and IV insulin delivery, combined with a closed-loop controller provide effective blood glucose management
SeraMaster Version 2 – Intravenous blood glucose measurement with subjects with type 1 diabetes
Evaluation of the automatic blood sampling, including sample preparation
Developing a Novel Automated Intravenous Insulin Delivery System. An In Silico Study Characterizing the Glucose Measurement Effect on the System’s Performance
SeraMaster – Intravenous Blood Glucose Measurement; YSI Reference
SeraMaster – Intravenous Blood Glucose Measurement; Cobas C111 reference
Long-Term Testing of Blood Sampling and Dilution via the In-House Developed Catheter
A BodyPort implantation for our automated glucose measuring device for diabetes care was successfully tested in an animal trial.
In healthy people, pancreas regulates blood glucose in such a way that it is practically always within the target range. The so-called “time in range” (% of the time in 24 hours during which the blood ...
In discussions with analysts and potential investors, we occasionally hear the argument that there is no relevant need for the Seraccess Diabetes Care project, “because Novartis (Alcon) and Google (Verily) are on the way to solving the problem.”
Subscribe to the Securecell Newsletter and stay up to date with all the latest product news, events and announcements. Don't miss out on any upcoming releases and conferences.